Tumor cells exhibit altered metabolism characterized by increased glycolysis and lactate production, even under aerobic conditions—a phenomenon known as the Warburg effect. Catalysts, particularly enzymes, are crucial in these metabolic pathways. By modulating the activity of these enzymes, researchers can potentially disrupt the metabolic processes that tumors rely on for growth and survival.
